The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly.

Top 5 Upgrades:
Deutsche Bank upgraded Palantir (PLTR) to Buy from Hold with an unchanged price target of $200. The firm views the company's Q2 report as "exceptional."
Oppenheimer upgraded Inspire Medical (INSP) to Outperform from Perform with an $85 price target. The firm notes the company's Q2 revenues of $201M slightly outpaced estimates, and argues that at these levels, there is "noisy" value to the story as a mid to high single digit grower.
UBS upgraded BBB Foods (TBBB) to Buy from Neutral with a price target of $51, up from $43. The company has delivered same-store-sales well ahead of inflation and its business benefits from consumers seeking value, the firm tells investors in a research note.
Leerink upgraded Replimune (REPL) to Outperform from Market Perform with a price target of $17, up from $11. The firm has "high conviction" the FDA will grant RP-1 plus nivolumab accelerated approval.

#price #target #calls